Weeks to Hours: Accelerating Drug Discovery with AIP | Novartis at AIPCon 8 @palantirtech
Weeks to Hours: Accelerating Drug Discovery with AIP | Novartis at AIPCon 8  @palantirtech
Uploaded September 2025 | Updated November 2026, 13 hours ago
At AIPCon 8, Birgit Schoeberl, Head of Data42 at Novartis, provides a rare showing of Palantir’s work in commercial pharmaceuticals. Through the comprehensive Ontology, with tens of billions of rows of data from 3000 clinical trials with more than 1M patients — a future of agentic R&D is accelerating drug discovery.
Weeks to Hours: Accelerating Drug Discovery with AIP | Novartis at AIPCon 8How American Industry Wins the AI Era | AIPCon 9 DiscussionAmerican Builder Summit | Shyam Sankar’s Closing RemarksPalantir Sovereignty Bootcamp | July 2026American Builder Summit | Mitch Parker, Dallas TX & Jonah Mericle, Norfolk, VAChad & Craig | Data Migrations with AI FDEProduct Launch: DevX: SuperRepo & Agent Development | DevCon 6AI on the GroundStartup Fellowship 002: Monq | DevCon 6Valley Forge Grantees Discuss Their Summer 2026 Projects with Chad WahlquistFrom 9/11 to AI: Mike Gallagher on How American Workers Will Win the 21st CenturyFeature Release: Query the Ontology Directly in Ontology SQL | DevCon 6
Palantir |

Weeks to Hours: Accelerating Drug Discovery with AIP | Novartis at AIPCon 8

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER